Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2018 07:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease Portfolio

— Expands portfolio to four marketed antibiotics, with peak sales potential over $1 billion —— Creates premier commercial stage global antibiotic franchise with the addition of Vabomere™(meropenem and...